Social network
Media - Staying connected to our latest news and events
Media - Staying connected to our latest news and events


Staying connected to our latest news and events

Tools content (print, share, increase/decrease text size):


    Middle area:

    Press releases 2012

    Press releases are intended to journalists, analysts and investors.

    Merial to Acquire Animal Health Division of Dosch Pharmaceuticals in India

    December 20, 2012

    Sanofi President, Global Operations, to retire

    December 18, 2012

    Amended Accounting Standard on Employee Benefits (IAS19R) applicable as from January 1, 2013

    December 18, 2012

    Genzyme and Isis Provide Update on CHMP Opinion on KYNAMRO™ (mipomersen)

    December 14, 2012

    Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint

    December 09, 2012

    Sanofi Compounds to be Featured in 178 Abstracts at American Society of Hematology Annual Meeting

    December 03, 2012

    Sanofi launches Awareness Campaign for Air France passengers on the Risks of Counterfeit Medicines

    November 30, 2012

    Sanofi Ranks Third on the Access to Medicine Foundation’s 2012 ATM Index

    November 28, 2012

    Sanofi Donates $500,000 to Hurricane Sandy Immediate and Long-Term Relief Efforts

    November 19, 2012

    Sanofi Receives Positive CHMP Opinion in the European Union for Once-Daily Lyxumia® (lixisenatide)

    November 16, 2012

    ZALTRAP® (aflibercept) Receives CHMP Positive Opinion in the European Union for Previously Treated Metastatic Colorectal Cancer

    November 16, 2012

    Sanofi Appoints Dr. Gary J. Nabel as Chief Scientific Officer

    November 14, 2012

    Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes

    November 14, 2012

    Sanofi and Institut Pasteur Honor Innovation in Biomedical Research with the Sanofi-Institut Pasteur 2012 Awards

    November 13, 2012

    Sanofi successfully prices EUR 750 million bond issue

    November 07, 2012

    Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia

    November 05, 2012

    Genzyme Announces Publication of LEMTRADA (alemtuzumab) Pivotal Studies in The Lancet

    October 31, 2012

    Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine

    October 31, 2012

    Q3 2012 Business EPS reflects patent expirations. Growth Platforms reached over 70% of sales

    October 25, 2012

    FDA Advisory Committee Recommends KYNAMRO™ for Homozygous Familial Hypercholesterolemia

    October 18, 2012

    Genzyme Presents Second Phase III Study of Once-daily Oral AUBAGIO® (teriflunomide) Confirming Significant Impact on Disability

    October 12, 2012

    Sanofi to Launch State-of-the Art, Reusable Insulin Pen AllStar™ in India

    October 09, 2012

    Genzyme to Present New Data from AUBAGIO and LEMTRADA Clinical Development Programs at ECTRIMS

    October 09, 2012

    Sanofi Announces Final Results of its Modified Dutch Auction Tender Offer for its Outstanding Contingent Value Rights

    October 08, 2012

    Journal of Clinical Oncology Publishes Phase III Results of ZALTRAP® (aflibercept) VELOUR Study in Previously Treated Metastatic Colorectal Cancer

    October 08, 2012

    New data from ORIGIN Shows Lantus® use is about 3 times more likely to achieve and sustain target HbA1c vs. standard care over 5 years in the study population

    October 05, 2012

    Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement

    October 03, 2012

    Sanofi to Acquire Genfar S.A., a Leader in Pharmaceutical Medicines in Colombia

    October 02, 2012

    Lyxumia® (lixisenatide) in Combination with Basal Insulin plus Oral Anti-Diabetics Significantly Improved Glycemic Control

    October 02, 2012

    Genzyme Phase 3 Study of Oral Compound Eliglustat Tartrate for Gaucher Disease Meets Primary Endpoint

    October 02, 2012

    Sanofi appoints Dr. Paul Chew, Chief Medical Officer and Head of Global Medical Affairs

    October 01, 2012

    EASD Abstracts Highlight Sanofi Commitment to Advancing Therapeutic Solutions in Diabetes Care

    September 26, 2012

    Sanofi provides information on the adaptation of its activities in France through 2015

    September 25, 2012

    Sanofi and TB Alliance Announce Collaboration to Accelerate New Treatments Against Tuberculosis

    September 20, 2012

    FDA Approves Genzyme’s AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis

    September 12, 2012

    Sanofi Pasteur Announces Publication in The Lancet of World's First Efficacy Results for its Dengue Vaccine Candidate

    September 11, 2012

    Sanofi Launches Modified Dutch Auction Tender Offer to Purchase up to 86,766,040 of its Outstanding Contingent Value Rights

    September 04, 2012

    Genzyme Provides Update on U.S. LEMTRADA™ Filing

    August 27, 2012

    Sanofi Announces FDA Approval for Auvi-Q™, First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies

    August 13, 2012

    U.S. FDA Approves ZALTRAP® (ziv-aflibercept) after Priority Review for Previously Treated Metastatic Colorectal Cancer

    August 03, 2012

    Availability Online of the Group’s Half-Year Financial Report for 2012

    July 27, 2012

    As expected, Q2 2012 Business EPS impacted by the loss of exclusivity of Plavix® and Avapro® in the U.S.

    July 26, 2012

    Sanofi Pasteur’s Dengue Vaccine Demonstrates Proof of Efficacy

    July 25, 2012

    Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program with LDL Cholesterol-Lowering PCSK9 Antibody

    July 20, 2012

    Sanofi to divest its stake in the Yves Rocher Group

    July 04, 2012

    Sanofi Pasteur’s 6-in-1 Pediatric Vaccine Hexaxim™ Receives Positive Opinion from European Medicines Agency

    June 22, 2012

    Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes

    June 19, 2012

    Sanofi Voted Leading Pan-European Quoted Company for Investor Relations in the 2012 Thomson Reuters Extel Survey

    June 13, 2012

    Genzyme Submits Applications to FDA and EMA for Approval of LEMTRADA™ (alemtuzumab) for Multiple Sclerosis

    June 12, 2012

    New Epidemiological Data Provide Additional Safety Evidence for Lantus®

    June 11, 2012

    Sanofi Announces Results of ORIGIN, the World’s Longest and Largest Randomized Clinical Trial in Pre- and Early Diabetes

    June 11, 2012

    Sanofi Submits Application for Regulatory Approval for Lyxumia® (lixisenatide) for the Treatment of Type 2 Diabetes in Japan

    June 11, 2012

    Lyxumia® (lixisenatide) in Combination with Basal Insulin plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose

    June 09, 2012

    Lantus® Initiation after Metformin Achieved Superior Glycemic Control versus Sitagliptin in Type 2 Diabetes

    June 09, 2012

    Genzyme Reports Positive Top-Line Results of TOWER, a Pivotal Phase III Trial for AUBAGIO™ (teriflunomide) in Relapsing Multiple Sclerosis

    June 01, 2012

    Sanofi Inaugurates Lantus® SoloSTAR® Pen Assembly Plant in its Beijing Facility

    May 28, 2012

    Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet

    May 26, 2012

    ASCO Abstracts Highlight Late-stage Sanofi Oncology Pipeline

    May 17, 2012

    Combined General Shareholder Meeting of May 4, 2012

    May 04, 2012

    Genzyme Announces Regulatory Approvals of Expanded Waterford, Ireland Manufacturing Plant

    May 03, 2012

    Japan Chooses Sanofi Pasteur for First Enhanced Inactivated Polio Vaccine

    April 27, 2012

    Strong performance in Q1 2012 including Genzyme contribution

    April 27, 2012

    Significant Improvement in Disability Scores Observed in Multiple Sclerosis Patients Who Received Lemtrada™ (Alemtuzumab) Compared With Rebif® in Phase lll Trial

    April 24, 2012

    Genzyme Demonstrates Depth of MS Pipeline at AAN with Results from Multiple Sclerosis Phase lll Trials

    April 20, 2012

    Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson’s Disease

    April 19, 2012

    Sanofi and Regeneron Announce Regulatory and Clinical Update for Zaltrap® (aflibercept

    April 05, 2012

    Merial Acquires Newport Laboratories

    April 02, 2012

    Sanofi and Regeneron Report Phase 2 Data for Potential First-in-Class Lipid-Lowering PCSK9 Antibody

    March 26, 2012

    Sanofi to Acquire Pluromed, Inc., Expanding its Presence in Biosurgery

    March 16, 2012

    Filing of the 2011 U.S. Form 20-F and French “Document de Référence” Containing the Annual Financial Report

    March 07, 2012

    Composition of Sanofi’s Board of Directors

    March 05, 2012

    Sanofi appoints Jean-Luc Lowinski, Senior Vice President, Asia Region

    March 02, 2012

    Genzyme Begins Shipping Fabrazyme from Newly Approved Framingham Manufacturing Plant

    March 01, 2012

    Sanofi and the Institut Pasteur Create Four Prestigious Awards to Support Innovative Biomedical Research

    February 27, 2012

    2011 Results Benefit from Genzyme Acquisition. Net Sales and Business EPS up 9.2% in Q4

    February 08, 2012

    Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex

    February 08, 2012

    Sanofi Commits to Eliminate or Control Five Neglected Tropical Diseases

    January 30, 2012

    Genzyme Announces FDA Approval of Framingham Manufacturing Plant

    January 24, 2012

    Brazil Introduces Inactivated Polio Vaccine in National Immunization Program with Sanofi Pasteur Vaccine

    January 18, 2012

    Genzyme Announces European Approval of Framingham Manufacturing Plant

    January 18, 2012

    Sanofi and Venture Capital Firms, Third Rock Ventures and Greylock Partners, Jointly Launch Warp Drive Bio, a Biotechnology Company Combining Innovative Genomics Technologies for Natural Products Drug Discovery

    January 10, 2012

    Right area:




    Filter by date


    © Sanofi 2004-2016 - All rights reserved - Update: March 12, 2015

    • Site complies with W3C WCAG 2.0 (new window, in english)